Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Cited by CrossRef (36)

  1. C. Austin Zamarripa, Shelley R. Edwards, Hina N. Qureshi, John N. Yi, Bruce E. Blough, Kevin B. Freeman. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats. Drug and Alcohol Dependence 2018;192:158
    https://doi.org/10.1016/j.drugalcdep.2018.08.002
  2. Steffen Hahnel, Nic Wheeler, Zhigang Lu, Arporn Wangwiwatsin, Paul McVeigh, Aaron Maule, Matthew Berriman, Timothy Day, Paula Ribeiro, Christoph G. Grevelding, James B. Lok. Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni. PLoS Pathog 2018;14:e1006718
    https://doi.org/10.1371/journal.ppat.1006718
  3. Nanshan Song, Yinquan Fang, Xiyang Sun, Qingling Jiang, Chenghuan Song, Miaomiao Chen, Jianhua Ding, Ming Lu, Gang Hu. Salmeterol, agonist of β2-aderenergic receptor, prevents systemic inflammation via inhibiting NLRP3 inflammasome. Biochemical Pharmacology 2018;150:245
    https://doi.org/10.1016/j.bcp.2018.02.009
  4. Thomas M. Tzschentke, Kris Rutten. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat. Neuropharmacology 2018;129:100
    https://doi.org/10.1016/j.neuropharm.2017.11.026
  5. Min Woo Kim, Wenjing Wang, Mateo I Sanchez, Robert Coukos, Mark von Zastrow, Alice Y Ting. Time-gated detection of protein-protein interactions with transcriptional readout. 2017;6
    https://doi.org/10.7554/eLife.30233
  6. Dongyun Zhang, Anthony P. Heaney. Prolactin Disorders. 2017.
    https://doi.org/10.1007/978-3-030-11836-5_13
  7. Mohammad M. Ahmadzai, David Broadbent, Christopher Occhiuto, Canchai Yang, Rupali Das, Hariharan Subramanian. G Protein-Coupled Receptors in Immune Response and Regulation. 2017.
    https://doi.org/10.1016/bs.ai.2017.05.004
  8. Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres, John R. Hepler, Alan V. Smrcka. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease. Pharmacol Rev 2018;70:446
    https://doi.org/10.1124/pr.117.015354
  9. Jolien Storme, Annelies Cannaert, Kathleen Van Craenenbroeck, Christophe P. Stove. Molecular dissection of the human A 3 adenosine receptor coupling with β-arrestin2. Biochemical Pharmacology 2018;148:298
    https://doi.org/10.1016/j.bcp.2018.01.008
  10. Xin Ma, Yunfang Xiong, Leo Lee. Application of Nanoparticles for Targeting G Protein-Coupled Receptors. IJMS 2018;19:2006
    https://doi.org/10.3390/ijms19072006
  11. Anneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, Jordi Doijen, Marta Arimont, Chunxia Zhao, Raimond Heukers, Rebecca Rimkunas, Chris de Graaf, Theo Verrips, Bas van der Woning, Hans de Haard, Joseph B. Rucker, Kurt Vermeire, Tracy Handel, Tom Van Loy, Martine J. Smit, Dominique Schols. CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry. Biochemical Pharmacology 2018;158:402
    https://doi.org/10.1016/j.bcp.2018.10.015
  12. Abraham Madariaga-Mazón, Andrés F. Marmolejo-Valencia, Yangmei Li, Lawrence Toll, Richard A. Houghten, Karina Martinez-Mayorga. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?. Drug Discovery Today 2017;22:1719
    https://doi.org/10.1016/j.drudis.2017.07.002
  13. Kyeong-Man Kim. Conceptual Progress for the Improvements in the Selectivity and Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview. Biomolecules & Therapeutics 2017;25:1
    https://doi.org/10.4062/biomolther.2016.262
  14. Leif Hertz, Ye Chen. Glycogenolysis, an Astrocyte-Specific Reaction, is Essential for Both Astrocytic and Neuronal Activities Involved in Learning. Neuroscience 2018;370:27
    https://doi.org/10.1016/j.neuroscience.2017.06.025
  15. Thomas M. Tzschentke, Babette Y. Kögel, Stefanie Frosch, Klaus Linz. Limited potential of cebranopadol to produce opioid-type physical dependence in rodents. Addiction Biology 2018;23:1010
    https://doi.org/10.1111/adb.12550
  16. Hidetoshi Komatsu, Mamoru Fukuchi, Yugo Habata. Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders. IJMS 2019;20:3207
    https://doi.org/10.3390/ijms20133207
  17. Liang Tan, Wenzhong Yan, John D. McCorvy, Jianjun Cheng. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. J. Med. Chem. 2018;61:9841
    https://doi.org/10.1021/acs.jmedchem.8b00435
  18. Xiaofei E, Paul Meraner, Ping Lu, Jill M. Perreira, Aaron M. Aker, William M. McDougall, Ronghua Zhuge, Gary C. Chan, Rachel M. Gerstein, Patrizia Caposio, Andrew D. Yurochko, Abraham L. Brass, Timothy F. Kowalik. OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism. Proc Natl Acad Sci USA 2019;116:7043
    https://doi.org/10.1073/pnas.1814850116
  19. Jolien Storme, Dilip K. Tosh, Zhan-Guo Gao, Kenneth A. Jacobson, Christophe P. Stove. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives. Biochemical Pharmacology 2018;158:103
    https://doi.org/10.1016/j.bcp.2018.10.003
  20. Supachoke Mangmool, Warisara Parichatikanond, Hitoshi Kurose. Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.01336
  21. Terry Kenakin, Eric L. Barker. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267
    https://doi.org/10.1124/pr.118.016790
  22. Thomas M. Tzschentke, Klaus Linz, Thomas Koch, Thomas Christoph. The Nociceptin/Orphanin FQ Peptide Receptor. 2019.
    https://doi.org/10.1007/164_2019_206
  23. Yusuke Shintani, Atsuko Hayata-Takano, Keita Moriguchi, Takanobu Nakazawa, Yukio Ago, Atsushi Kasai, Kaoru Seiriki, Norihito Shintani, Hitoshi Hashimoto, Arun Shukla. β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking. PLoS ONE 2018;13:e0196946
    https://doi.org/10.1371/journal.pone.0196946
  24. Teja Devarakonda, Fadi N. Salloum. Heart Disease and Relaxin: New Actions for an Old Hormone. Trends in Endocrinology & Metabolism 2018;29:338
    https://doi.org/10.1016/j.tem.2018.02.008
  25. Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, Jia Zhou. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. J. Med. Chem. 2019;62:88
    https://doi.org/10.1021/acs.jmedchem.8b00875
  26. Jingwei Bian, Suli Zhang, Ming Yi, Mingming Yue, Huirong Liu. The mechanisms behind decreased internalization of angiotensin II type 1 receptor. Vascular Pharmacology 2018;103-105:1
    https://doi.org/10.1016/j.vph.2018.01.008
  27. Guido Iaccarino, Daniela Sorriento. Encyclopedia of Endocrine Diseases. 2018.
    https://doi.org/10.1016/B978-0-12-801238-3.95888-4
  28. Kamila Szymańska, Joanna Kałafut, Alicja Przybyszewska, Beata Paziewska, Grzegorz Adamczuk, Michał Kiełbus, Adolfo Rivero-Müller. FSHR Trans-Activation and Oligomerization. Front. Endocrinol. 2018;9
    https://doi.org/10.3389/fendo.2018.00760
  29. Mohammad Golam Sabbir, Paul Fernyhough. Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons. Neuropharmacology 2018;143:268
    https://doi.org/10.1016/j.neuropharm.2018.09.020
  30. Valerie T. Ramirez, Wesley E. P. A. van Oeffelen, Cristina Torres-Fuentes, Barbara Chruścicka, Clementine Druelle, Anna V. Golubeva, Marcel van de Wouw, Timothy G. Dinan, John F. Cryan, Harriët Schellekens. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists. The FASEB Journal 2019;33:518
    https://doi.org/10.1096/fj.201800655R
  31. Cristina Torres-Fuentes, Elena Pastor-Cavada, Rafael Cano, Dalia Kandil, Rachel Shanahan, Rocio Juan, Hamdy Shaban, Gerard McGlacken, Harriët Schellekens. Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia. IJMS 2018;19:1605
    https://doi.org/10.3390/ijms19061605
  32. Shaherin Basith, Minghua Cui, Stephani J. Y. Macalino, Jongmi Park, Nina A. B. Clavio, Soosung Kang, Sun Choi. Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.00128
  33. Mohammed Nooraldeen Mahmod Al-Qattan, Mohd Nizam Mordi. Molecular Basis of Modulating Adenosine Receptors Activities. CPD 2019;25:817
    https://doi.org/10.2174/1381612825666190304122624
  34. Hideaki Kanki, Tsutomu Sasaki, Shigenobu Matsumura, Satoru Yokawa, Toshiro Yukami, Munehisa Shimamura, Manabu Sakaguchi, Tadahide Furuno, Takahiro Suzuki, Hideki Mochizuki. β-arrestin-2 in PAR-1-biased signaling has a crucial role in endothelial function via PDGF-β in stroke. Cell Death Dis 2019;10
    https://doi.org/10.1038/s41419-019-1375-x
  35. Ichio Shimada, Takumi Ueda, Yutaka Kofuku, Matthew T. Eddy, Kurt Wüthrich. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat Rev Drug Discov 2019;18:59
    https://doi.org/10.1038/nrd.2018.180
  36. Chayma El Khamlichi, Flora Reverchon-Assadi, Nadège Hervouet-Coste, Lauren Blot, Eric Reiter, Séverine Morisset-Lopez. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology. Molecules 2019;24:537
    https://doi.org/10.3390/molecules24030537